Oncology PracticeBeyond Weight Loss, Limited Bariatric Surgery Benefits in Older AdultsSeptember 12, 2024GastroenterologyPreventive CareASCO Breast CancerGenitourinary Cancer
Oncology PracticeOutcomes with CDK4/6 Inhibitors Vary in BCJuly 30, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeWhat Does Hormone Receptor Mean in BRCA-Associated BC?July 29, 2024ASCO Breast CancerBreast Cancer
Oncology PracticeBlack Women With Breast Cancer Face Clinical InequitiesJuly 26, 2024ASCO Breast CancerBreast CancerDiversity in Medicine
Oncology PracticeCirculating Tumor DNA Hints at BC Recurrence RiskJuly 24, 2024ASCO Breast CancerBreast Cancer
Oncology PracticeCognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BCJuly 17, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeEribulin Similar to Taxane When Paired With Dual HER2 Blockade in BCJuly 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticePFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast CancerJuly 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeNew ADC results mixed in metastatic breast cancerJuly 8, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeAdjuvant Avelumab Benefits Seen in High Risk, Triple Negative BCJuly 8, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticePlatinum Add-On Improves Survival in Early TNBCJune 25, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeInavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BCJune 19, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeSurviving to Thriving: Enhancing Quality of Life in Breast CancerJune 17, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeT-DXd Moves Toward First Line for HER2-Low Metastatic BCJune 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeAnti-Müllerian Hormone Predicts Chemo Benefits in BCJune 6, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
